Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06482554
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:25.070335+00:00
Published At
2024-07-01T00:00:00+00:00
Record Updated At
2024-07-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Apathy", "Schizophrenia", "Schizophrenia; Psychosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-01"
protocolSection.identificationModule.nctId
"NCT06482554"
protocolSection.identificationModule.officialTitle
"Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms."
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Apathy (protocolSection.conditionsModule.conditions)
  • Schizophrenia (protocolSection.conditionsModule.conditions)
  • Schizophrenia; Psychosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.